Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105920528 | 10592052 | 8 | F | 201410 | 20160725 | 20141119 | 20160726 | EXP | BR-ROCHE-1475268 | ROCHE | 53.82 | YR | M | Y | 90.00000 | KG | 20160727 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105920528 | 10592052 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | RECENT DOSE ON 22MAY2014 (DAY 15) | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 105920528 | 10592052 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | SOLUTION FOR INFUSION | ||||||||||
| 105920528 | 10592052 | 3 | SS | CIPROFLOXACIN HYDROCHLORIDE. | CIPROFLOXACIN HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 105920528 | 10592052 | 4 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 20 | MG | |||||||||
| 105920528 | 10592052 | 5 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105920528 | 10592052 | 1 | Rheumatoid arthritis |
| 105920528 | 10592052 | 2 | Rheumatoid arthritis |
| 105920528 | 10592052 | 3 | Furuncle |
| 105920528 | 10592052 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105920528 | 10592052 | HO |
| 105920528 | 10592052 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105920528 | 10592052 | Adenoidal hypertrophy | |
| 105920528 | 10592052 | Arthralgia | |
| 105920528 | 10592052 | Bronchospasm | |
| 105920528 | 10592052 | Cholelithiasis | |
| 105920528 | 10592052 | Drug ineffective | |
| 105920528 | 10592052 | Dyspnoea | |
| 105920528 | 10592052 | Erythema | |
| 105920528 | 10592052 | Furuncle | |
| 105920528 | 10592052 | Joint swelling | |
| 105920528 | 10592052 | Neck pain | |
| 105920528 | 10592052 | Peripheral swelling | |
| 105920528 | 10592052 | Pneumonia | |
| 105920528 | 10592052 | Spinal pain | |
| 105920528 | 10592052 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105920528 | 10592052 | 1 | 20131210 | 20141001 | 0 | |
| 105920528 | 10592052 | 2 | 20151101 | 0 |